| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $642.0M | +169.4% |
| Cost of Revenue | $145.0M | +134.6% |
| Gross Profit | $497.0M | +181.6% |
| R&D Expense | $219.8M | +143.6% |
| SG&A Expense | $241.2M | +87.2% |
| Operating Income | -$316.8M | -178.0% |
| Interest Expense | $9.4M | -66.5% |
| Pre-tax Income | -$330.7M | -137.3% |
| Income Tax | -$4.3M |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.60B | +213.3% |
| Accounts Receivable | $24.0M | +32.0% |
| Current Assets | $6.28B | +74.1% |
| Total Assets | $9.26B | +55.1% |
| Current Liabilities | $3.41B | +46.6% |
| Long-term Debt | $1.77B | +79.2% |
| Total Liabilities | $5.21B | +51.5% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.1M | -491.4% |
| Capital Expenditures | $5.4M | -71.6% |
| Investing Cash Flow | -$1.13B | +21.0% |
| Financing Cash Flow | $2.88B | +75.6% |
| Free Cash Flow | -$23.5M | -64.4% |
| +89.4% |
| Net Income | -$326.4M | -230.6% |
| EPS (Basic) | -$3.21 | -169.7% |
| EPS (Diluted) | -$3.21 | -169.7% |
| Stockholders' Equity |
| $4.04B |
| +59.9% |